News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
GLOCER THOMAS H
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/03/2023 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 437 options to buy
@ $102.95, valued at
$45k
|
|
07/05/2023 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 390 options to buy
@ $115.39, valued at
$45k
|
|
06/02/2023 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on MORGAN STANLEY
Txns:
| Granted 3,168 shares
@ $0 Granted 1,218 shares
@ $82.0752, valued at
$100k
|
|
05/31/2023 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 1,981 options to buy
@ $111.07, valued at
$220k
|
|
05/05/2023 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on MORGAN STANLEY
Txns:
| Sold 4,535 shares
@ $87.105, valued at
$395k
|
|
05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
04/03/2023 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 423 options to buy
@ $106.39, valued at
$45k
|
|
01/03/2023 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 406 options to buy
@ $110.95, valued at
$45k
|
|
12/02/2022 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on MORGAN STANLEY
Txns:
| Granted 862 shares
@ $92.813, valued at
$80k
|
|
10/04/2022 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 523 options to buy
@ $86.12, valued at
$45k
|
|
07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/01/2022 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 137 options to buy
@ $82.05, valued at
$11.2k
|
|
01/04/2022 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 147 options to buy
@ $76.64, valued at
$11.3k
|
|
12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/03/2020 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on MORGAN STANLEY
Txns:
| Granted 1,265 shares
@ $63.2464, valued at
$80k
|
|
06/03/2020 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on MORGAN STANLEY
Txns:
| Granted 5,588 shares
@ $0 Granted 1,788 shares
@ $44.7421, valued at
$80k
|
|
06/02/2020 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 2,478 options to buy
@ $80.72, valued at
$200k
|
|
04/02/2020 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 227 options to buy
@ $76.94, valued at
$17.5k
|
|
01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2019 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on MORGAN STANLEY
Txns:
| Granted 1,614 shares
@ $49.5691, valued at
$80k
|
|
10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2019 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 201 options to buy
@ $83.85, valued at
$16.9k
|
|
06/04/2019 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 2,336 options to buy
@ $79.21, valued at
$185k
|
|
06/04/2019 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on MORGAN STANLEY
Txns:
| Granted 6,110 shares
@ $0 Granted 1,955 shares
@ $40.9183, valued at
$80k
|
|
04/02/2019 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 406 options to buy
@ $83.17, valued at
$33.8k
|
|
02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2019 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns:
| Granted 442 options to buy
@ $76.41, valued at
$33.7k
|
|
12/04/2018 |
4
| GLOCER THOMAS H (Director) has filed a Form 4 on MORGAN STANLEY
Txns:
| Granted 1,638 shares
@ $44.273, valued at
$72.5k
|
|
|
|
|